Hinge Health, “the San Francisco-based company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, like back and joint pain,” recently secured $400 million in Series E funding.
The new funding was co-lead by Tiger Global and Coatue Management, alongside Alkeon Capital and Whale Rock.
The new investment brings Hinge Health’s total funds raised to over $1 billion and is “now one of the most valuable companies in digital health.” To help lead the company, Hinge Health recently welcomed Lalith Vadlamannati as its new chief technology officer.
Hinge Health offers revolutionary technology that reduces MSK pain, surgeries, and opioid use.
The brand features advanced wearable sensors and computer technology that is overseen by physical therapists, physicians, and board-certified health coaches.